INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsHighNeutral
Announced Fri, 8 Aug · 21:28 IST

Intimation under Regulation 30 of SEBI (LODR) 2015 Filling of Form INC-28 with Registrar of Companies

Nclt Scheme FiledStrategic Transactions View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories Limited has announced that the Scheme of Arrangement for the Amalgamation of Ind Swift Limited (Transferor Company) with itself (Transferee Company) has become effective from 8th August, 2025. Both companies have filed Form INC-28 with the Registrar of Companies on the same date, completing the formalities of the merger. This follows an earlier intimation dated 31st July, 2025. The amalgamation covers both companies along with their respective shareholders and creditors. Ind Swift Limited will now merge into Ind-Swift Laboratories Limited as per the approved scheme.

Likely market impact

The merger consolidates Ind Swift Limited into Ind-Swift Laboratories Limited, which could simplify the group structure and potentially lead to operational synergies. Shareholders of Ind-Swift Laboratories may see changes in shareholding pattern and financials as the transferor company gets absorbed. Shareholders of Ind Swift Limited will receive shares of the transferee company as per the swap ratio approved in the scheme.